Mirvetuximab

DB16235InvestigationalProtein Based Therapies

Mirvetuximab: Overview.

Mechanism
Curator reviewed
Also known as
Immunoglobulin g1, anti-(human folate receptor .alpha.) (human-mus musculus monoclonal m9346a heavy chain), disulfide with human-mus musculus monoclonal m9346a light chain, dimer
Code names
M-9346A

Resolves to

Compound
UNII4MFH3B1EFUCAS1453084-36-0
Targets
P15328FOLR1

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Mirvetuximab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In